A meta-analysis of CD4+ T cell epitope maps reveals clusters and gaps in envelope-protein (E protein) immunogenicity that can be explained by the likelihood of epitope processing, as determined by E protein three-dimensional structures. Differential processing may be at least partially responsible for variations in disease severity among arbo-flaviruses and points to structural features that modulate protection from disease.
Get full access to this article
View all access options for this article.
References
1.
AntoniouAN, BlackwoodSL, MazzeoD, et al.Control of antigen presentation by a single protease cleavage site. Immunity, 2000; 12:391–398.
2.
BhattS, GethingPW, BradyOJ, et al.The global distribution and burden of dengue. Nature, 2013; 496:504–507.
3.
BressanelliS, StiasnyK, AllisonSL, et al.Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J, 2004; 23:728–738.
4.
BrienJD, UhrlaubJL, and Nikolich-ZugichJ. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol, 2008; 181:8568–8575.
5.
ChanJF, ChoiGK, YipCC, et al.Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease. J Infect, 2016; 72:507–524.
6.
ChienPCJr., CohenS, TuenM, et al.Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing. J Virol, 2004; 78:7645–7652.
7.
CroweSR, MillerSC, BrownDM, et al.Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine, 2006; 24:457–467.
8.
D'OrtenzioE, MatheronS, YazdanpanahY, et al.Evidence of sexual transmission of zika virus. N Engl J Med, 2016; 374:2195–2198.
9.
DaepCA, Muñoz-JordánJL, and EugeninEA. Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. J Neurovirol, 2014; 20:539–560.
10.
FiebigerE, MeranerP, WeberE, et al.Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med, 2001; 193:881–892.
11.
FritzR, StiasnyK, and HeinzFX. Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol, 2008; 183:353–361.
12.
GessnerBD, and Wilder-SmithA. Estimating the public health importance of the CYD-tetravalent dengue vaccine: vaccine preventable disease incidence and numbers needed to vaccinate. Vaccine, 2016; 34:2397–2401.
13.
GoncalvesAJS, OliveiraERA, CostaSM, et al.Cooperation between CD4+T cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen. Plos Negl Trop Dis, 2015; 9:22.
14.
HallTA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser, 1999; 41:95–98.
15.
HilserVJ, and FreireE. Structure-based calculation of the equilibrium folding pathway of proteins. Correlation with hydrogen exchange protection factors. J Mol Biol, 1996; 262:756–772.
16.
IijimaN, and IwasakiA. Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help. Nature, 2016; 533:552–556.
17.
JamesEA, GatesTJ, LaFondRE, et al.Neuroinvasive West nile infection elicits elevated and atypically polarized T cell responses that promote a pathogenic outcome. PLoS Pathog, 2016; 12:e1005375.
18.
JamesEA, LaFondRE, GatesTJ, et al.Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins. J Virol, 2013; 87:12794–12804.
KanaiR, KarK, AnthonyK, et al.Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol, 2006; 80:11000–11008.
21.
KleinDE, ChoiJL, and HarrisonSC. Structure of a dengue virus envelope protein late-stage fusion intermediate. J Virol, 2013; 87:2287–2293.
22.
KollaritschH, Paulke-KorinekM, HolzmannH, et al.Vaccines and vaccination against tick-borne encephalitis. Expert Rev Vaccines, 2012; 11:1103–1119.
23.
KoradiR, BilleterM, and WuthrichK. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph, 1996; 14:51–55, 29–32.
L'AzouM, MoureauA, SartiE, et al.Symptomatic dengue in children in 10 Asian and latin American countries. N Engl J Med, 2016; 374:1155–1166.
26.
LiJ, ChenH, WuN, et al.Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice. Vaccine, 2013; 31:4136–4142.
27.
LiJ, GaoN, FanD, et al.Cross-protection induced by Japanese encephalitis vaccines against different genotypes of dengue viruses in mice. Sci Rep, 2016; 6:19953.
28.
LucaVC, AbiMansourJ, NelsonCA, et al.Crystal structure of the Japanese encephalitis virus envelope protein. J Virol, 2012; 86:2337–2346.
29.
LucaVC, NelsonCA, and FremontDH. Structure of the St. Louis encephalitis virus postfusion envelope trimer. J Virol, 2013; 87:818–828.
30.
MacielM, KellathurSN, ChikhlikarP, et al.Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB/c (H2d) mice model. Virology, 2008; 378:105–117.
31.
MalhotraD, LinehanJL, DileepanT, et al.Tolerance is established in polyclonal CD4(+) T cells by distinct mechanisms, according to self-peptide expression patterns. Nat Immunol, 2016; 17:187–195.
32.
MartinsKA, CooperCL, StronskySM, et al.Adjuvant-enhanced CD4 T cell responses are critical to durable vaccine immunity. EBioMedicine, 2016; 3:67–78.
33.
MellmanI. Dendritic cells: master regulators of the immune response. Cancer Immunol Res, 2013; 1:145–149.
34.
MettuRR, CharlesT, and LandrySJ. CD4+ T-cell epitope prediction using antigen processing constraints. J Immunol Methods, 2016; 432:72–81.
35.
MlakarJ, KorvaM, TulN, et al.Zika virus associated with microcephaly. N Engl J Med, 2016; 374:951–958.
36.
ModisY, OgataS, ClementsD, et al.Structure of the dengue virus envelope protein after membrane fusion. Nature, 2004; 427:313–319.
37.
MuangchanaC, HenprasertthaeN, NurachK, et al.Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case–control study. Vaccine, 2012; 30:361–367.
38.
NascimentoEJ, MailliardRB, KhanAM, et al.Identification of conserved and HLA promiscuous DENV3 T-cell epitopes. PLoS Negl Trop Dis, 2013; 7:e2497.
39.
NelsonRW, BeisangD, TuboNJ, et al.T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity. Immunity, 2015; 42:95–107.
40.
NielsenM, and LundO. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics, 2009; 10:296.
41.
OlagnierD, PeriS, SteelC, et al.Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. PLoS Pathog, 2014; 10:e1004566.
42.
PaulS, Lindestam ArlehamnCS, ScribaTJ, et al.Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. J Immunol Methods, 2015; 422:28–34.
43.
PlotkinSA. Correlates of protection induced by vaccination. Clin Vaccine Immunol, 2010; 17:1055–1065.
44.
ReyFA, HeinzFX, MandlC, et al.The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature, 1995; 375:291–298.
45.
RivinoL, KumaranEA, JovanovicV, et al.Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. J Virol, 2013; 87:2693–2706.
46.
RochePA, and CresswellP. Antigen processing and presentation mechanisms in myeloid cells. Microbiol Spectr, 2016; 4 [Epub ahead of print]; DOI: 10.1128/microbiolspec.MCHD-0008-2015
47.
RoehrigJT, RisiPA, BrubakerJR, et al.T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology, 1994; 198:31–38.
48.
SchneiderSC, OhmenJ, FosdickL, et al.Cutting edge: introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. J Immunol, 2000; 165:20–23.
49.
SchwaigerJ, AberleJH, StiasnyK, et al.Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction. J Virol, 2014; 88:7828–7842.
50.
ScreatonG, MongkolsapayaJ, YacoubS, et al.New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol, 2015; 15:745–759.
51.
SharminS, GlassK, ViennetE, et al.A Bayesian approach for estimating under-reported dengue incidence with a focus on non-linear associations between climate and dengue in Dhaka, Bangladesh. Stat Methods Med Res, 2016 DOI: 10.1177/0962280216649216.
52.
SimmonsCP, DongT, ChauNV, et al.Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol, 2005; 79:5665–5675.
53.
StiasnyK, and HeinzFX. Flavivirus membrane fusion. J Gen Virol, 2006; 87:2755–2766.
54.
TanGS, LeonPE, AlbrechtRA, et al.Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection. PLoS Pathog, 2016; 12:e1005578.
55.
TurtleL, BaliT, BuxtonG, et al.Human T cell responses to Japanese encephalitis virus in health and disease. J Exp Med, 2016; 213:1331–1352.
56.
van der MostRG, HarringtonLE, GiuggioV, et al.Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice. Virology, 2002; 296:117–124.
57.
WassermanS, TambyahPA, and LimPL. Yellow fever cases in Asia: primed for an epidemic. Int J Infect Dis, 2016; 48:98–103.
58.
WeiskopfD, BangsDJ, SidneyJ, et al.Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci U S A, 2015; 112:E4256–E4263.
59.
ZhangX, ChengX, YuL, et al.MCOLN1 is a ROS sensor in lysosomes that regulates autophagy. Nat Commun, 2016; 7:12109.
